The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Müllerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications
Abstract
Dr. Alfred Jost pioneered the field of reproductive endocrinology with his seminal observation that two hormones produced by the testes are required for the male embryo to develop a normal internal reproductive tract. T induces the Wolffian ducts to differentiate into epididymides, vasa deferens, and seminal vesicles. Müllerian inhibiting substance (MIS) causes regression of the Müllerian ducts, which in its absence would normally develop into the Fallopian tubes, uterus, and upper vagina as is observed in female embryos. This review will summarize our current understanding of molecular mechanisms underlying the function of MIS both as a fetal gonadal hormone that causes Müllerian duct regression and as an adult hormone, the roles for which are currently being investigated, i.e., inhibition of steroidogenesis, germ cell development, and cancer. We will also address the regulation of MIS expression as one of the first genes expressed after the commitment of the bipotential gonads to differentiate into testes under the influence of SRY, the gene on the sex-determining region of the Y chromosome. We will discuss what is known regarding MIS signal transduction, which as with other members of the TGFbeta family of growth and differentiation factors, occurs through a heteromeric complex of single transmembrane serine/threonine kinase receptors to effect downstream signaling events, including Smad, nuclear factor-kappaB, beta-catenin, and p16 activation. Finally, we will assess the clinical relevance of studying MIS in patients with persistent Müllerian duct syndrome and our efforts to determine the therapeutic value of MIS for patients with ovarian and other MIS receptor-expressing cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
MECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,017
Controlling TGF-beta signaling.
Massagué, J., & Chen, Y. (2000) · PubMed · Cited by 1,780
Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F. D., Keutel, J., Hustert, E., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90041-8 · Cited by 1,618
Massagué, J., & Chen, Y.-G. (2000) · Genes & Development · doi:10.1101/gad.14.6.627 · Cited by 1,575
TGFβ signals through a heteromeric protein kinase receptor complex
Wrana, J. L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., & Massague, J. (1992) · Cell · doi:10.1016/0092-8674(92)90395-s · Cited by 1,526
Vacanti, J. P., & Langer, R. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90247-7 · Cited by 1,323
Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P., & Mark, M. (2000) · Development · doi:10.1242/dev.127.19.4277 · Cited by 1,064
Cate, R. L., Mattaliano, R. J., Hession, C., Tizard, R., Farber, N. M., Cheung, A., Ninfa, E. G., Frey, A. Z., Gash, D. J., Chow, E. P., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90783-x · Cited by 1,022
Self-citationControl of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1
Durlinger, A. L. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (1999) · Endocrinology · doi:10.1210/endo.140.12.7204 · Cited by 1,011
Saunders, J. W. (1966) · Science · doi:10.1126/science.154.3749.604 · Cited by 952
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
da Silva, S. M., Hacker, A., Harley, V., Goodfellow, P., Swain, A., & Lovell-Badge, R. (1996) · Nature Genetics · doi:10.1038/ng0996-62 · Cited by 795
Muscatelli, F., Strom, T. M., Walker, A. P., Zanaria, E., Récan, D., Meindl, A., Bardoni, B., Guioli, S., Zehetner, G., Rabl, W., et al. (1994) · Nature · doi:10.1038/372672a0 · Cited by 767
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors
Cheifetz, S., Weatherbee, J. A., Tsang, M. L.-S., Anderson, J. K., Mole, J. E., Lucas, R., & Massagué, J. (1987) · Cell · doi:10.1016/0092-8674(87)90192-9 · Cited by 706
Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1
Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., & Dyson, N. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81254-4 · Cited by 698
A transcriptional partner for MAD proteins in TGF-β signalling
Chen, X., Rubock, M. J., & Whitman, M. (1996) · Nature · doi:10.1038/383691a0 · Cited by 684
Müllerian-inhibiting substance function during mammalian sexual development
Behringer, R. R., Finegold, M. J., & Cate, R. L. (1994) · Cell · doi:10.1016/0092-8674(94)90251-8 · Cited by 679
Walsh, P. C., Madden, J. D., Harrod, M. J., Goldstein, J. L., MacDonald, P. C., & Wilson, J. D. (1974) · New England Journal of Medicine · doi:10.1056/nejm197410312911806 · Cited by 631
A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal
Bardoni, B., Zanaria, E., Guioli, S., Floridia, G., Worley, K. C., Tonini, G., Ferrante, E., Chiumello, G., McCabe, E. R. B., Fraccaro, M., et al. (1994) · Nature Genetics · doi:10.1038/ng0894-497 · Cited by 610
De Santa Barbara, P., Bonneaud, N., Boizet, B., Desclozeaux, M., Moniot, B., Sudbeck, P., Scherer, G., Poulat, F., & Berta, P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6653 · Cited by 604
Wilms’ tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.
Nachtigal, M. W., Hirokawa, Y., Enyeart-VanHouten, D. L., Flanagan, J. N., Hammer, G. D., & Ingraham, H. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81172-1 · Cited by 591
Shen, W.-H., Moore, C. C. D., Ikeda, Y., Parker, K. L., & Ingraham, H. A. (1994) · Cell · doi:10.1016/0092-8674(94)90050-7 · Cited by 559
A Dosage Sensitive Locus at Chromosome Xp21 Is Involved in Male to Female Sex Reversal
Bardoni, B., Zanaria, E., Guioli, S., Floridia, G., Worley, K. C., Tonini, G., Ferrante, E., Chiumello, G., McCabe, E. R. B., Fraccaro, M., et al. (1995) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199502000-00020 · Cited by 539
Feng, X.-H., Zhang, Y., Wu, R.-Y., & Derynck, R. (1998) · Genes & Development · doi:10.1101/gad.12.14.2153 · Cited by 525
TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300
Janknecht, R., Wells, N. J., & Hunter, T. (1998) · Genes & Development · doi:10.1101/gad.12.14.2114 · Cited by 507
Münsterberg, A., & Lovell-Badge, R. (1991) · Development · doi:10.1242/dev.113.2.613 · Cited by 480
SMADs: mediators and regulators of TGF-β signaling
Kretzschmar, M., & Massagué, J. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80069-5 · Cited by 467
Baarends, W. M., Uilenbroek, J. T., Kramer, P., Hoogerbrugge, J. W., van Leeuwen, E. C., Themmen, A. P., & Grootegoed, J. A. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588229 · Cited by 461
Roy, A. L., Meisterernst, M., Pognonec, P., & Roeder, R. G. (1991) · Nature · doi:10.1038/354245a0 · Cited by 457
Targeted Mutagenesis of the Endogenous Mouse Mis Gene Promoter
Arango, N. A., Lovell-Badge, R., & Behringer, R. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81527-5 · Cited by 449
Jernvall, J., Åberg, T., Kettunen, P., Keränen, S., & Thesleff, I. (1998) · Development · doi:10.1242/dev.125.2.161 · Cited by 445
Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance
Behringer, R. R., Cate, R. L., Froelick, G. J., Palmiter, R. D., & Brinster, R. L. (1990) · Nature · doi:10.1038/345167a0 · Cited by 437
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood
Lee, M. M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.571 · Cited by 431
SRY AND SEX DETERMINATION IN MAMMALS
Goodfellow, P. N., & Lovell-Badge, R. (1993) · Annual Review of Genetics · doi:10.1146/annurev.ge.27.120193.000443 · Cited by 426
Disorders of sex differentiation
Grumbach, M. M. (1992) · Medical Entomology and Zoology · Cited by 402
The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors
Wang, T., Li, B.-Y., Danielson, P. D., Shah, P. C., Rockwell, S., Lechleider, R. J., Martin, J., Manganaro, T., & Donahoe, P. K. (1996) · Cell · doi:10.1016/s0092-8674(00)80116-6 · Cited by 388
Self-citationThe type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb
Yi, S. E., Daluiski, A., Pederson, R., Rosen, V., & Lyons, K. M. (2000) · Development · doi:10.1242/dev.127.3.621 · Cited by 385
Rajpert-De Meyts, E., Jørgensen, N., Græm, N., Müller, J., Cate, R. L., & Skakkebæk, N. E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6047 · Cited by 373
Richards, J. S. (2001) · Molecular Endocrinology · doi:10.1210/me.15.2.209 · Cited by 368
Mechanism of TGFβ receptor inhibition by FKBP12
Chen, Y.-G., Liu, F., & Massagué, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3866 · Cited by 363
Viger, R. S., Mertineit, C., Trasler, J. M., & Nemer, M. (1998) · Development · doi:10.1242/dev.125.14.2665 · Cited by 362
Mammalian sex determination: a molecular drama
Swain, A., & Lovell-Badge, R. (1999) · Genes & Development · doi:10.1101/gad.13.7.755 · Cited by 361
Mishina, Y., Rey, R., Finegold, M. J., Matzuk, M. M., Josso, N., Cate, R. L., & Behringer, R. R. (1996) · Genes & Development · doi:10.1101/gad.10.20.2577 · Cited by 359
Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a
Parr, B. A., & McMahon, A. P. (1998) · Nature · doi:10.1038/27221 · Cited by 356
Lillie, F. R. (1916) · Science · doi:10.1126/science.43.1113.611 · Cited by 350
Physical and Functional Interaction of SMADs and p300/CBP
Pouponnot, C., Jayaraman, L., & Massagué, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.22865 · Cited by 349
Mullerian Inhibiting Substance: A Gonadal Hormone with Multiple Functions*
LEE, M. M., & DONAHOE, P. K. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-152 · Cited by 345
Self-citationDewulf, N. (1995) · Endocrinology · doi:10.1210/en.136.6.2652 · Cited by 332
Gañan, Y., Macias, D., Duterque-Coquillaud, M., Ros, M. A., & Hurle, J. M. (1996) · Development · doi:10.1242/dev.122.8.2349 · Cited by 321
Rajpert-De Meyts, E. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3836 · Cited by 291
Baarends, W. M., Helmond, M. J. L. V., Post, M., Schoot, P. J. C. M. V. D., Hoogerbrugge, J. W., Winter, J. P. D., Uilenbroek, J. T. J., Karels, B., Wilming, L. G., Meijers, J. H. C., et al. (1994) · Development · doi:10.1242/dev.120.1.189 · Cited by 290
Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
di Clemente, N., Wilson, C., Faure, E., Boussin, L., Carmillo, P., Tizard, R., Picard, J. Y., Vigier, B., Josso, N., & Cate, R. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.8.7997230 · Cited by 287
Capel, B. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00327-5 · Cited by 283
Foster, J. W., & Graves, J. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1927 · Cited by 281
Cunha, G. R., Alarid, E. T., Turner, T., et al. (1993) · PubMed · Cited by 277
Anti-Müllerian Hormone: The Jost Factor
JOSSO, N., CATE, R. L., PICARD, J.-Y., VIGIER, B., DI CLEMENTE, N., WILSON, C., IMBEAUD, S., PEPINSKY, R. B., GUERRIER, D., BOUSSIN, L., et al. (1993) · Recent Progress in Hormone Research · doi:10.1016/b978-0-12-571148-7.50005-1 · Cited by 248
Gu, Z., Reynolds, E. M., Song, J., Lei, H., Feijen, A., Yu, L., He, W., MacLaughlin, D. T., Raaij, J. V. D. E.-V., Donahoe, P. K., et al. (1999) · Development · doi:10.1242/dev.126.11.2551 · Cited by 245
Self-citationTremblay, J., & Viger, R. S. (2001) · Endocrinology · doi:10.1210/en.142.3.977 · Cited by 239
Tremblay, J. J. (1999) · Molecular Endocrinology · doi:10.1210/me.13.8.1388 · Cited by 238
Recent progress in ovarian cancer
Scully, R. E. (1970) · Human Pathology · doi:10.1016/s0046-8177(70)80005-3 · Cited by 236
Al-Attar, L., Noël, K., Dutertre, M., Belville, C., Forest, M. G., Burgoyne, P. S., Josso, N., & Rey, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119653 · Cited by 235
Imbeaud, S., Faure, E., Lamarre, I., Mattéi, M.-G., di Clemente, N., Tizard, R., Carré-Eusèbe, D., Belville, C., Tragethon, L., Tonkin, C., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-382 · Cited by 228
CUNHA, G. R., ALARID, E. T., TURNER, T., DONJACOUR, A. A., BOUTIN, E. L., & FOSTER, B. A. (1992) · Journal of Andrology · doi:10.1002/j.1939-4640.1992.tb00338.x · Cited by 219
Anti-Müllerian hormone produces endocrine sex reversal of fetal ovaries.
Vigier, B., Forest, M. G., Eychenne, B., Bézard, J., Garrigou, O., Robel, P., & Josso, N. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3684 · Cited by 207
Rey, R. A., Belville, C., Nihoul-Fékété, C., Michel-Calemard, L., Forest, M. G., Lahlou, N., Jaubert, F., Mowszowicz, I., David, M., Saka, N., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5507 · Cited by 205
Pepinsky, R. B., Sinclair, L. K., Chow, E. P., Mattaliano, R. J., Manganaro, T. F., Donahoe, P. K., & Cate, R. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37375-7 · Cited by 201
Self-citationTsao, S.-W., Mok, S. C., Fey, E. G., Fletcher, J. A., Wan, T. S. K., Chew, E.-C., Muto, M. G., Knapp, R. C., & Berkowitz, R. S. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1184 · Cited by 201
Anti-Müllerian hormone in early human development
Josso, N., Lamarre, I., Picard, J.-Y., Berta, P., Davies, N., Morichon, N., Peschanski, M., & Jeny, R. (1993) · Early Human Development · doi:10.1016/0378-3782(93)90204-8 · Cited by 199
Lee, M. M., Donahoe, P. K., Silverman, B. L., Hasegawa, T., Hasegawa, Y., Gustafson, M. L., Chang, Y., & MacLaughlin, D. T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705223362102 · Cited by 199
Self-citationGiuili, G., Shen, W.-H., & Ingraham, H. A. (1997) · Development · doi:10.1242/dev.124.9.1799 · Cited by 198
Wilson, J. D., Harrod, M. J., Goldstein, J. L., Hemsell, D. L., & MacDonald, P. C. (1974) · New England Journal of Medicine · doi:10.1056/nejm197405162902001 · Cited by 191
Rey, R., Lordereau-Richard, I., Carel, J. C., Barbet, P., Cate, R. L., Roger, M., Chaussain, J. L., & Josso, N. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.5.8077315 · Cited by 185
Trelstad, R. L., Hayashi, A., Hayashi, K., & Donahoe, P. K. (1982) · Developmental Biology · doi:10.1016/0012-1606(82)90147-6 · Cited by 180
Self-citationBlanchard, M.-G., & Josso, N. (1974) · Pediatric Research · doi:10.1203/00006450-197412000-00011 · Cited by 174
Clarke, T. R. (2001) · Molecular Endocrinology · doi:10.1210/me.15.6.946 · Cited by 171
Molecular mechanisms of hormone-mediated Müllerian duct regression: involvement of β-catenin
Allard, S., Adin, P., Gouédard, L., di Clemente, N., Josso, N., Orgebin‐Crist, M., Picard, J., & Xavier, F. (2000) · Development · doi:10.1242/dev.127.15.3349 · Cited by 170
He, W. W., Gustafson, M. L., Hirobe, S., & Donahoe, P. K. (1993) · Developmental Dynamics · doi:10.1002/aja.1001960207 · Cited by 166
Self-citationHirobe, S. (1992) · Endocrinology · doi:10.1210/en.131.2.854 · Cited by 165
Gouédard, L., Chen, Y.-G., Thevenet, L., Racine, C., Borie, S., Lamarre, I., Josso, N., Massagué, J., & di Clemente, N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002704200 · Cited by 163
Schreiber, M., Muller, W. J., Singh, G., & Graham, F. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202466 · Cited by 162
Seminara, S. B., Achermann, J. C., Genel, M., Jameson, J. L., & Crowley, W. F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6172 · Cited by 160
The Serine/Threonine Transmembrane Receptor ALK2 Mediates Mullerian Inhibiting Substance Signaling
Visser, J. A. (2001) · Molecular Endocrinology · doi:10.1210/me.15.6.936 · Cited by 159
Imbeaud, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.9.1269 · Cited by 158
Effect of Anti-Mullerian Hormone on Sertoli and Leydig Cell Functions in Fetal and Immature Rats1
Rouiller, V., Carmona, S., Merhi, R. A., Cate, R. L., Habert, R., & Vigier, B. (1998) · Endocrinology · doi:10.1210/endo.139.3.5785 · Cited by 153
Watanabe, K., Clarke, T. R., Lane, A. H., Wang, X., & Donahoe, P. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1624 · Cited by 149
Self-citationMüllerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFκB-mediated Pathway
Segev, D. L., Ha, T. U., Tran, T. T., Kenneally, M., Harkin, P. D., Jung, M., MacLaughlin, D. T., Donahoe, P. K., & Maheswaran, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004554200 · Cited by 142
Self-citationKnebelmann, B., Boussin, L., Guerrier, D., Legeai‐Mallet, L., Kahn, A., Josso, N., & Picard, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3767 · Cited by 139
Wilson, C. A., di Clemente, N., Ehrenfels, C. W., Pepinsky, R. B., Josso, N., Vigier, B., & Cate, R. L. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.2.8469238 · Cited by 137
Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3
Kawamura, C., Kizaki, M., Yamato, K., Uchida, H., Fukuchi, Y., Hattori, Y., Koseki, T., Nishihara, T., & Ikeda, Y. (2000) · Blood · doi:10.1182/blood.v96.6.2005 · Cited by 135
Seminara, S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4501 · Cited by 134
Nachtigal, M. W., & Ingraham, H. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7711 · Cited by 132
di Clemente, N., Goxe, B., Rémy, J., Cate, R. L., Josso, N., Vigier, B., & Salesse, R. (1994) · HAL · Cited by 132
Cellular Localization of Mullerian Inhibiting Substance in the Developing Rat Ovary
UENO, S., Takahashi, M., Manganaro, T. F., Ragin, R. C., & Donahoe, P. K. (1989) · Endocrinology · doi:10.1210/endo-124-2-1000 · Cited by 126
Self-citationMullerian Inhibitory Substance Induces Growth of Rat Preantral Ovarian Follicles1
McGee, E. A., Smith, R., Spears, N., Nachtigal, M. W., Ingraham, H. A., & Hsueh, A. J. W. (2001) · Biology of Reproduction · doi:10.1095/biolreprod64.1.293 · Cited by 125
Dyche, W. J. (1979) · Journal of Morphology · doi:10.1002/jmor.1051620203 · Cited by 124
NF-κB Inhibits Apoptosis in Murine Mammary Epithelia
Clarkson, R. W. E., Heeley, J. L., Chapman, R. S., Aillet, F., Hay, R. T., Wyllie, A. H., & Watson, C. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12737 · Cited by 112
Antimullerian Hormone in Patients with Hypogonadotropic Hypogonadism
Young, J., Rey, R. A., Couzinet, B., Chanson, P., Josso, N., & SCHAISON, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5972 · Cited by 111
Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells
Dejardin, E., Deregowski, V., Chapelier, M., Jacobs, N., GIELEN, J. E., Merville, M., & Bours, V. (1999) · Oncogene · doi:10.1038/sj.onc.1202599 · Cited by 110
Cloning and Expression of the Chick Anti-Müllerian Hormone Gene
Carre, D. S., di Clemente, N., Rey, R. A., Pieau, C., Vigier, B., Josso, N., & Picard, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.4798 · Cited by 109
Cloning and expression of cDNA for anti-müllerian hormone.
Picard, J., Bénarous, R., Guerrier, D., Josso, N., & Kahn, A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.15.5464 · Cited by 108
Tremblay, J., & Viger, R. S. (2001) · Biology of Reproduction · doi:10.1095/biolreprod64.4.1191 · Cited by 108
GENE INTERACTIONS IN GONADAL DEVELOPMENT
Parker, K. L., Schedl, A., & Schimmer, B. P. (1999) · Annual Review of Physiology · doi:10.1146/annurev.physiol.61.1.417 · Cited by 107
Josso, N. (1973) · Endocrinology · doi:10.1210/endo-93-4-829 · Cited by 102
Müllerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism
Ha, T. U., Segev, D. L., Barbie, D. A., Masiakos, P. T., Tran, T. T., Dombkowski, D., Glander, M., Clarke, T. R., Lorenzo, H. K., Donahoe, P. K., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005701200 · Cited by 98
Self-citationGhosh‐Choudhury, N., Woodruff, K. A., Qi, W., Celeste, A. J., Abboud, S. L., & Choudhury, G. G. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2844 · Cited by 87
Mullerian Inhibiting Substance Activity in Bovine Fetal, Newborn and Prepubertal Testes1
Donahoe, P. K., Ito, Y., Price, J. M., & Hendren, W. H. (1977) · Biology of Reproduction · doi:10.1095/biolreprod16.2.238 · Cited by 85
Self-citationJosso, N. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-2-265 · Cited by 84
Donahoe, P. K., Swann, D. A., Hayashi, A., & Sullivan, M. (1979) · Science · doi:10.1126/science.472712 · Cited by 84
Self-citationSynergistic effects of inhibins and mullerian-inhibiting substance on testicular tumorigenesis
Matzuk, M. M., Finegold, M. J., Mishina, Y. M., Bradley, A., & Behringer, R. R. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.10.8544842 · Cited by 83
Programmed cell death in the Müllerian duct induced by Müllerian inhibiting substance
Price, J. M., Donahoe, P. K., Ito, Y., & Hendren, W. H. (1977) · American Journal of Anatomy · doi:10.1002/aja.1001490304 · Cited by 81
Self-citationKuroda, T., Lee, M. M., Haqq, C. M., Powell, D., Manganaro, T. F., & Donahoe, P. K. (1990) · Endocrinology · doi:10.1210/endo-127-4-1825 · Cited by 80
Self-citationZauberman, A., Oren, M., & Zipori, D. (1997) · Oncogene · doi:10.1038/sj.onc.1201348 · Cited by 77
Geymayer, S., & Doppler, W. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1159 · Cited by 75
MacLaughlin, D. T., Hudson, P. L., Graciano, A. L., Kenneally, M., Ragin, R. C., Manganaro, T. F., & Donahoe, P. K. (1992) · Endocrinology · doi:10.1210/endo.131.1.1612008 · Cited by 72
Self-citationAutocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
Ingraham, H. A., Hirokawa, Y., Roberts, L. M., Sh, M., McGee, E. A., Nachtigal, M. W., & Ja, V. (2000) · PubMed · Cited by 70
Ragin, R. C., Donahoe, P. K., Kenneally, M., et al. (1992) · Protein Expression and Purification · doi:10.1016/1046-5928(92)90020-w · Cited by 69
Self-citationSeifer, D. B., MacLaughlin, D. T., Penzias, A. S., Behrman, H. R., Asmundson, L., Donahoe, P. K., Haning, R. V., & Flynn, S. D. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445031 · Cited by 69
Self-citationTFII Is Required for Transcription of the Naturally TATA-less but Initiator-containing Vβ Promoter
Manzano‐Winkler, B., Novina, C. D., & Roy, A. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.12076 · Cited by 66
Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents
Trbovich, A. M., Sluss, P. M., Laurich, V. M., O’Neill, F. H., MacLaughlin, D. T., Donahoe, P. K., & Teixeira, J. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051632298 · Cited by 63
Self-citationHuman müllerian inhibiting substance inhibits tumor growth in vitro and in vivo.
Chin, T., Parry, R. L., & Donahoe, P. K. (1991) · PubMed · Cited by 61
Self-citationMALE SEX DETERMINATION: Current Concepts of Male Sexual Differentiation
Gustafson, M. L., & Donahoe, P. K. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.505 · Cited by 59
Self-citationCatlin, E. A., Tonnu, V. C., Ebb, R. G., Pacheco, B. A., Manganaro, T. F., Ezzell, R. M., Donahoe, P. K., & Teixeira, J. M. (1997) · Endocrinology · doi:10.1210/endo.138.2.4906 · Cited by 56
Self-citationTeixeira, J. M., Kehas, D. J., Antun, R., & Donahoe, P. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13831 · Cited by 48
Self-citationIkawa, H., Trelstad, R. L., Hutson, J. M., Manganaro, T. F., & Donahoe, P. K. (1984) · Developmental Biology · doi:10.1016/0012-1606(84)90190-8 · Cited by 47
Self-citationPeriductal and matrix glycosaminoglycans in rat Mullerian duct development and regression
Hayashi, A., Donahoe, P. K., Budzik, G. P., & Trelstad, R. L. (1982) · Developmental Biology · doi:10.1016/0012-1606(82)90146-4 · Cited by 46
Self-citationAstrocyte Progression from G1 to S Phase of the Cell Cycle Depends upon Multiple Protein Interaction
Pedram, A., Razandi, M., Ren-ming, H., & Levin, E. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13966 · Cited by 42
Price, J. M., Donahoe, P. K., & Ito, Y. (1979) · American Journal of Anatomy · doi:10.1002/aja.1001560207 · Cited by 38
Self-citationSteroidogenic factor 1 plays multiple roles in endocrine development and function.
Wong, M., Ikeda, Y., Luo, X., Caron, K. M., Weber, T. J., Swain, A., Schimmer, B. P., & Parker, K. L. (1997) · PubMed · Cited by 37
Evaluation of the infant who has ambiguous genitalia, and principles of operative management.
Donahoe, P. K., & Schnitzer, J. (1996) · PubMed · Cited by 31
Self-citationAlterations of the p16INK4A gene in human ovarian cancers
Kanuma, T., Nishida, J., Gima, T., Barrett, J. C., & Wake, N. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199703)18:3<134::aid-mc2>3.0.co;2-f · Cited by 23
Cited by
Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily
Chang, H., Brown, C. W., & Matzuk, M. M. (2002) · Endocrine Reviews · doi:10.1210/er.2002-0003 · Cited by 787
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications
Broer, S. L., Broekmans, F. J. M., Laven, J. S. E., & Fauser, B. C. J. M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu020 · Cited by 683
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
Sex Determination and Differentiation
MacLaughlin, D. T., & Donahoe, P. K. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022784 · Cited by 454
Self-citationFortune, J. E. (2003) · Animal Reproduction Science · doi:10.1016/s0378-4320(03)00088-5 · Cited by 383
Metadata
- Authors
- Teixeira, J., Maheswaran, S., & Donahoe, P. K.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2001-10-01
- Volume
- 22
- Issue
- 5
- Pages
- 657-674
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2156708806
- Cited by
- 326
- References
- 133
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.